July 05, 2018
A New Jersey federal judge Thursday dismissed Sunovion Pharmaceuticals Inc.'s patent infringement suit against MSN Laboratories and Sandoz Inc. over its bipolar medication Latuda after the parties reached a deal and MSN agreed to delay its generic version of the drug until Sunovion's patent expires.
February 15, 2017
A New Jersey federal judge on Tuesday blocked Emcure Pharmaceuticals Ltd. and Teva Pharmaceutical Industries Ltd. from moving forward with generic versions of Sunovion Pharmaceuticals Inc.'s bipolar disorder medication Latuda, and that same day, Sunovion filed another infringement suit against MSN Laboratories and Sandoz Inc. over the drug.